AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.

British-Swedish pharmaceutical giant AstraZeneca endured a torrid time in China last year, as it underwent several investigations and saw one of its senior executives detained by authorities.

Warren Buffett's Berkshire Hathaway (BRK-B) has increased its stakes in Japan's largest trading houses, according to reports.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. AstraZeneca has been hit with a US class action lawsuit that claims the UK’s largest listed company ...

AstraZeneca is hopping aboard the pickleball craze as its serves up a new marketing push for its asthma med Fasenra. The injectable drug will serve as an official partner of the Professional ...